JAC Advance Access originally published online on May 30, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):320-326; doi:10.1093/jac/dkl217
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England
1 Healthcare-Associated Infection and Antimicrobial Resistance Department, Health Protection Agency Centre for Infections 61 Colindale Avenue, London NW9 5EQ, UK 2 Antibiotic Resistance Monitoring and Reference Laboratory, Health Protection Agency Centre for Infections 61 Colindale Avenue, London NW9 5EQ, UK
Received 20 January 2006; returned 13 March 2006; revised 5 May 2006; accepted 8 May 2006
*Corresponding author. Tel: +44-208-327-7217; Fax: +44-208-205-9185; E-mail: nicola.potz{at}HPA.org.uk
Objectives: To investigate the molecular epidemiology of Enterobacteriaceae producing extended-spectrum ß-lactamases (ESBLs) in London and South-East England.
Methods: A prospective study involving 16 hospital microbiology laboratories in London and South-East England was undertaken over a 12 week period. Each laboratory submitted up to 100 consecutive cephalosporin-resistant Enterobacteriaceae isolates judged clinically significant by microbiology staff. Centralized testing was undertaken to confirm organism identification and cephalosporin resistance and to analyse resistance mechanisms.
Results: The predominant mechanism of cephalosporin resistance in isolates from both hospital and community settings was the production of CTX-M-type ESBLs, with CTX-M-producing Escherichia coli as the most numerous resistant organism overall. Other major mechanisms of cephalosporin resistance included production of non-CTX-M ESBLs and AmpC ß-lactamases. Most ESBL (both CTX-M and non-CTX-M) producers were multiply resistant to non-ß-lactam antibiotics, including trimethoprim, ciprofloxacin and gentamicin.
Conclusions: CTX-M enzymes, which were unrecorded in the UK prior to 2000, have become the major mechanism of cephalosporin resistance in Enterobacteriaceae in South-East England. E. coli has overtaken Klebsiella and Enterobacter spp. to become the major host for ESBLs. Due to the multiple antibiotic resistance exhibited by many ESBL-producers, these changes have major implications for antimicrobial therapy.
Keywords: ESBLs , CTX-M enzymes , E. coli
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. J. Baudry, K. Nichol, M. DeCorby, L. Mataseje, M. R. Mulvey, D. J. Hoban, and G. G. Zhanel Comparison of Antimicrobial Resistance Profiles among Extended-Spectrum-{beta}-Lactamase-Producing and Acquired AmpC {beta}-Lactamase-Producing Escherichia coli Isolates from Canadian Intensive Care Units Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1846 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Madec, C. Lazizzera, P. Chatre, D. Meunier, S. Martin, G. Lepage, M.-F. Menard, P. Lebreton, and T. Rambaud Prevalence of Fecal Carriage of Acquired Expanded-Spectrum Cephalosporin Resistance in Enterobacteriaceae Strains from Cattle in France J. Clin. Microbiol., April 1, 2008; 46(4): 1566 - 1567. [Full Text] [PDF]
|
|
|
|
 |
|
 Risks of extended-spectrum beta-lactamases DTB, March 1, 2008; 46(3): 21 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mammeri, F. Eb, A. Berkani, and P. Nordmann Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospital J. Antimicrob. Chemother., March 1, 2008; 61(3): 498 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mushtaq, R. Hope, M. Warner, and D. M. Livermore Activity of faropenem against cephalosporin-resistant Enterobacteriaceae J. Antimicrob. Chemother., May 1, 2007; 59(5): 1025 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. M. Ensor, D. M. Livermore, and P. M. Hawkey A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., March 1, 2007; 59(3): 387 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Livermore, R. Canton, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, et al. CTX-M: changing the face of ESBLs in Europe J. Antimicrob. Chemother., February 1, 2007; 59(2): 165 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hope, N. A. C. Potz, M. Warner, E. J. Fagan, E. Arnold, and D. M. Livermore Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae J. Antimicrob. Chemother., January 1, 2007; 59(1): 110 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Woodford, S. Reddy, E. J. Fagan, R. L. R. Hill, K. L. Hopkins, M. E. Kaufmann, J. Kistler, M.-F. I. Palepou, R. Pike, M. E. Ward, et al. Wide geographic spread of diverse acquired AmpC {beta}-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland J. Antimicrob. Chemother., January 1, 2007; 59(1): 102 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Hope, M. Warner, N. A. C. Potz, E. J. Fagan, D. James, and D. M. Livermore Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from South-East England J. Antimicrob. Chemother., December 1, 2006; 58(6): 1312 - 1314. [Full Text] [PDF]
|
|